Prof. Simon Rule provides an overview from the live meeting on Chemotherapy-free treatment approach in lymphoma. E-learning also available.
Watch the video, download the slides and take the e-learning
Hemato-oncology Experts Knowledge Share Video
Chemotherapy-free treatment approaches in lymphoma
Episode 1
Publication Date
Sep 2021
Programme summary
Duration 5 MIN
Downloadable resources Yes-
DOWNLOAD SLIDES PPTX
-
Language(s)
Other episodes in this series
Share this programme
Accreditation
This course has been accredited by EACCME® for ECMEC®.
Brought to you by
LYMPHOMA & MYELOMA CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Karyopharm Therapeutics and Menarini Stemline Oncology.
Meet the experts
Other programmes of interest
Video
Oncology Hemato-oncology
Early relapsed/refractory multiple myeloma (RRMM): best practices in management
A 3-part video series on managing early RRMM from leading medical experts
Experts
Dr Elena Zamagni, Dr Fredrik Schjesvold, Dr Joseph Mikhael-
Downloadable
Resources -
4 MIN
-
Sep 2024
Oncology Hemato-oncology
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)
Medical experts discuss the latest learnings from clinical practice
Experts
Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter-
Downloadable
Resources -
MIN
-
Jun 2024
Conference update
Episode
6
of 6
Oncology Hemato-oncology
Listen to Expert Insights on Late-Breaking Data from ASCO 2023
Episode 6: Lymphoma Update: SWOG S1826 trial
Experts
Dr Mansoor Raza Mirza, Dr Paolo Tarantino, Prof. Alexey V Danilov, Prof. Mark Socinski, Prof. Evan Yu, Prof. Thomas Powles, Assoc. Prof. Gerald Prager-
2 MIN
-
Jun 2023
Oncology Hemato-oncology
Update From ASH 2022
Highlights from the ASH Annual Meeting
Experts
Dr Matthew J. Matasar-
4 MIN
-
Dec 2022
Hemato-oncology
Update from ASCO 2022 – Myeloma
Dr Hans Lee summarises the highlights from the phase 3 DETERMINATION trial: Lenalidomide, bortezomib, and dexamethasone (RVd) ± autologous stem cell transplantation (ASCT) and R maintenance to progression for newly diagnosed multiple myeloma (NDMM)
Experts
Asst. Prof. Hans Lee-
2 MIN
-
May 2022
Podcast
Episode
3
of 3
Hemato-oncology
Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics
Episode 3: Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics
Experts
Assoc. Prof. María Victoria Mateos, Dr Alexander M Lesokhin-
Downloadable
Resources -
MIN
-
Mar 2022
